151 related articles for article (PubMed ID: 15183054)
1. Rescue of influenza virus expressing GFP from the NS1 reading frame.
Kittel C; Sereinig S; Ferko B; Stasakova J; Romanova J; Wolkerstorfer A; Katinger H; Egorov A
Virology; 2004 Jun; 324(1):67-73. PubMed ID: 15183054
[TBL] [Abstract][Full Text] [Related]
2. Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment.
Kittel C; Ferko B; Kurz M; Voglauer R; Sereinig S; Romanova J; Stiegler G; Katinger H; Egorov A
J Virol; 2005 Aug; 79(16):10672-7. PubMed ID: 16051859
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs.
Solórzano A; Webby RJ; Lager KM; Janke BH; García-Sastre A; Richt JA
J Virol; 2005 Jun; 79(12):7535-43. PubMed ID: 15919908
[TBL] [Abstract][Full Text] [Related]
4. A genetically engineered influenza A virus with ras-dependent oncolytic properties.
Bergmann M; Romirer I; Sachet M; Fleischhacker R; García-Sastre A; Palese P; Wolff K; Pehamberger H; Jakesz R; Muster T
Cancer Res; 2001 Nov; 61(22):8188-93. PubMed ID: 11719449
[TBL] [Abstract][Full Text] [Related]
5. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis.
Min JY; Li S; Sen GC; Krug RM
Virology; 2007 Jun; 363(1):236-43. PubMed ID: 17320139
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes.
Ferko B; Stasakova J; Romanova J; Kittel C; Sereinig S; Katinger H; Egorov A
J Virol; 2004 Dec; 78(23):13037-45. PubMed ID: 15542655
[TBL] [Abstract][Full Text] [Related]
7. The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation.
Donelan NR; Dauber B; Wang X; Basler CF; Wolff T; García-Sastre A
J Virol; 2004 Nov; 78(21):11574-82. PubMed ID: 15479798
[TBL] [Abstract][Full Text] [Related]
8. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
Talon J; Salvatore M; O'Neill RE; Nakaya Y; Zheng H; Muster T; García-Sastre A; Palese P
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4309-14. PubMed ID: 10725408
[TBL] [Abstract][Full Text] [Related]
9. Rubella virus DI RNAs and replicons: requirement for nonstructural proteins acting in cis for amplification by helper virus.
Tzeng WP; Chen MH; Derdeyn CA; Frey TK
Virology; 2001 Oct; 289(1):63-73. PubMed ID: 11601918
[TBL] [Abstract][Full Text] [Related]
10. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway.
Hayman A; Comely S; Lackenby A; Murphy S; McCauley J; Goodbourn S; Barclay W
Virology; 2006 Mar; 347(1):52-64. PubMed ID: 16378631
[TBL] [Abstract][Full Text] [Related]
11. A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody.
De Baets S; Verhelst J; Van den Hoecke S; Smet A; Schotsaert M; Job ER; Roose K; Schepens B; Fiers W; Saelens X
PLoS One; 2015; 10(3):e0121491. PubMed ID: 25816132
[TBL] [Abstract][Full Text] [Related]
12. The ORF, regulated synthesis, and persistence-specific variation of influenza C viral NS1 protein.
Marschall M; Helten A; Hechtfischer A; Zach A; Banaschewski C; Hell W; Meier-Ewert H
Virology; 1999 Jan; 253(2):208-18. PubMed ID: 9918879
[TBL] [Abstract][Full Text] [Related]
13. A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine Virus.
Chen C; Fan W; Li J; Zheng W; Zhang S; Yang L; Liu D; Liu W; Sun L
Front Cell Infect Microbiol; 2018; 8():127. PubMed ID: 29765910
[TBL] [Abstract][Full Text] [Related]
14. Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate.
Wressnigg N; Voss D; Wolff T; Romanova J; Ruthsatz T; Mayerhofer I; Reiter M; Nakowitsch S; Humer J; Morokutti A; Muster T; Egorov A; Kittel C
Vaccine; 2009 May; 27(21):2851-7. PubMed ID: 19366569
[TBL] [Abstract][Full Text] [Related]
15. MDCK cell line with inducible allele B NS1 expression propagates delNS1 influenza virus to high titres.
van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ
Vaccine; 2011 Sep; 29(40):6976-85. PubMed ID: 21787829
[TBL] [Abstract][Full Text] [Related]
16. Characterization of influenza virus NS1 protein by using a novel helper-virus-free reverse genetic system.
Enami M; Enami K
J Virol; 2000 Jun; 74(12):5556-61. PubMed ID: 10823862
[TBL] [Abstract][Full Text] [Related]
17. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
[TBL] [Abstract][Full Text] [Related]
18. Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain.
Kawano M; Kaito M; Kozuka Y; Komada H; Noda N; Nanba K; Tsurudome M; Ito M; Nishio M; Ito Y
Virology; 2001 May; 284(1):99-112. PubMed ID: 11352671
[TBL] [Abstract][Full Text] [Related]
19. Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis.
Salvatore M; Basler CF; Parisien JP; Horvath CM; Bourmakina S; Zheng H; Muster T; Palese P; García-Sastre A
J Virol; 2002 Feb; 76(3):1206-12. PubMed ID: 11773396
[TBL] [Abstract][Full Text] [Related]
20. Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling.
Zhirnov OP; Klenk HD
Apoptosis; 2007 Aug; 12(8):1419-32. PubMed ID: 17468837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
